U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442500) titled 'Drug Coated Balloon vs. Drug-eluting Stent in Patients With Coronary Artery Disease' on Feb. 24.
Brief Summary: Studies exploring the feasibility of drug-eluting balloon (DCB) in de-novo coronary lesions are limited. There are scarce data comparing DCB with drug-eluting stent (DES) in patients with high bleeding risk (HBR), a situation in which long-term maintenance of dual antiplatelet therapy (DAPT) is a clinical dilemma. This target trial emulation aims to compare clinical outcomes between DCB angioplasty and conventional DES implantation in de-novo coronary lesions in patients with coronary artery disease.
Study Start Date: Feb...